echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > To treat rheumatoid arthritis, go to the "heart"!

    To treat rheumatoid arthritis, go to the "heart"!

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *For medical professionals only

    Focus on social and psychological support for patients with RA
    .



    Strict management to improve treatment standards

    According to the large sample data of the Chinese Registry of Rheumatoid Arthritis (CREDIT) in China, only 9.


    Fortunately, in recent years, a variety of innovative targeted drugs such as barlotinib and tofatib have been approved for RA indications in China, enriching the treatment options of RA
    .


    Tian Xinping, et al.


    [3] Aletaha D, et al.


    Zhao Shangping, et al.


    Geng Yan, et al.



    Expert Profile
    Professor Wang Hongzhi's photo has been given the informed consent of the expert

    • Director of the Department of Rheumatology and Immunology of Jiaxing First Hospital Master tutor

    • He is the leader of key disciplines of medical support in Jiaxing City

    • The first chairman of the Rheumatology Branch of Jiaxing Medical Association

    • Vice Chairman of Rheumatology Branch of Zhejiang Medical Association

    • Leader of the chronic disease management group of the Rheumatology Branch of Zhejiang Medical Association


    Expert profile
    Professor Zhang Bin's photo has obtained the informed consent of the expert


    • Deputy Director of the Department of Rheumatology and Immunology of Jiaxing First Hospital

    • Jiaxing City the eighth batch of "351 talent project" discipline leader

    • He is the chairman of the Rheumatology Branch of Jiaxing Medical Association

    • Deputy Leader of the Chronic Disease Management Group of the Rheumatology Branch of Zhejiang Medical Association

    • He is a member of the Rheumatology and Immunology Branch of Zhejiang Medical Doctor Association

    PP-BA-CN-1938


    This article is for the sole purpose of providing scientific information to healthcare professionals and does not represent the position of the
    Platform.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.